Shattuck Labs Inc at Truist Securities Life Sciences Summit (May Series) Transcript
Welcome, everyone, to the next session. My name is Asthika Goonewardene, senior biotech analyst at Truist Securities. Great pleasure to have the team from Shattuck Labs on here now to discuss their exciting company. We have Taylor Schreiber, CEO and Co-Founder; and Andrew Neill, Chief Financial Officer, joining us here.
I will read out some quick disclosures. This call is arranged by Truist Securities Research for use by institutional investors and institutional clients as defined by FINRA. If you're not an institutional investor or issuer, please disconnect at this time. For required disclosures, please see our website at truistsecurities.com or our equity research library. Andrew why don't I hand it over to you to give us a little introduction to Shattuck Labs.
Sure. And, Asthika, can you see my slides properly?
Yes, I can.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |